An affiliate of the Georgia Institute of Technology, the Global Center for Medical Innovation (GCMI) helps verify, validate and accelerate commercialization of new medical technologies that save lives and improve patient care. From our Northyards and 14th Street facilities in midtown Atlanta, we help find the finish line for medtech innovations at any point on the pathway from bench to bedside. Principal investigators, faculty and student projects served include:

Dr. Andres Garcia
Dr. Scott Hollister
Dr. Omer Inan
Coulter Foundation
Over 20 additional GT faculty members

When Stars Align – Stridelink quickens its march to commercialization aligned with new remote monitoring capabilities and CMS CPT codes

Occasionally, even in the medtech innovation industry, stars align for a new technology to quickly, powerfully achieve commercialization and the associated clinical outcomes intended.   Such may well be the case for the team and technology at StrideLink.   As we reported last year, “StrideLink is a new technology venture, a first of its kind…

Early, consistent focus on the unmet need keeps Augment Health on a solid commercialization pathway

Stephen Kalinsky and Jared Meyers met on their first day as students in the Department of Biomedical Engineering at Georgia Tech. Five years later, the graduates have completed a 3-month tenure at ZeroTo510 in Memphis and are currently midstream in their endeavor to advance health and dignity for people dealing with spinal injuries or neurological…

A Scalable, Customized Solution to an Unmet Clinical Need Long in Need of Innovation

How GCMI supported Georgia Tech Spring 2022 Capstone Team UCOLLECT’s Need for Verification Testing on the pathway to commercialization.   “More than 6 in every 10 women will, at some point in their life, be unable to toilet. For these women, the best options include the Foley catheter, a device that is inserted up the…

Phase Zero and Phase One Services Accelerating Wearable Pediatric Stethoscope Path to Commercialization

“I can say with confidence our journey toward commercialization of our new [wearable pediatric stethoscope] medical technology would have taken years longer without GCMI’s Phase Zero and Phase One services.”   As the winner of the 2021 GCMI Baby Sharq Tank competition for their innovative wearable pediatric stethoscope, the interdisciplinary team of Dr. Hong Yeo,…

A Safer Way to Conduct Pericardiocentesis – A Procedure Begging for a Technology to Reduce Mortality

Meet Georgia Tech BME Fall 2021 Capstone Team Five of Hearts   The Unmet Need Heart disease, Viral infections, autoimmune diseases, and cancer can all cause excess fluid to fill the pericardial sac. Physicians frequently perform “pericardiocentesis” by inserting a large 18-gauge needle through the patient’s chest and into the pericardial space to drain this…

What high value preclinical support looks like when re-expressing pacemaking cells for cardiac arrhythmia in pediatrics

“Our confidence in data generated by our in vivo studies with T3 Labs cannot be greater.” – Dr. Hee Cheol Cho   The Preclinical Challenge Dr. Hee Cheol Cho and his team needed sufficient feasibility data from physiologically appropriate preclinical studies to pursue public funding opportunities to complete their translational research for a life changing…

Faculty Researchers and Innovators: What you need to know about IRBs and the medtech innovation process – Insights & Recording

New medical technologies or devices cannot enter stages of research or clinical trials in humans without certain authorizations required by regulatory agencies responsible for safety and efficacy. As far as those regulatory bodies are concerned, the path to clinical trials in humans is the same whether it’s research or commercial driven. Failing to walk that…

Georgia Tech researchers partner with GCMI to move their innovative IV Sensor closer to clinical trials

In 2014, a Children’s Healthcare of Atlanta nurse, Lynn Pogue, approached an engineer, Leanne West from Georgia Tech, to discuss the burden of IV monitoring. This is when Sherry Farrugia, the current Chief Executive Officer of GCMI, stepped in to help assemble the team that would begin the investigation into a new device capable of…

GCMI Capstone Support Spotlight: The Hemogoblins: Extending the Shelf Life of Cold Stored Whole Blood

According to the American Red Cross, every two seconds someone in the United States needs a blood transfusion. That fails to take into account injuries sustained by troops in war zones or others needing the precious resource in corners of the world that can take days or weeks to reach.   Yet currently, whole blood…